O'Shaughnessy Asset Management, LLC Aeterna Zentaris Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$0.77 - $1.08 $21,827 - $30,614	-28,347 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.0 - $2.97 $4,080 - $12,117	-4,080 Reduced 12.58%	28,347 $29,000
Q2 2019 Aug 07, 2019	BUY	$2.04 - $5.43 $15,047 - $40,051	7,376 Added 29.44%	32,427 $96,000
Q1 2019 May 10, 2019	BUY	$3.03 - $4.65 $7,635 - $11,718	2,520 Added 11.18%	25,051 $0
Q4 2018 Feb 12, 2019	BUY	$1.3 - $3.87 $29,290 - $87,194	22,531 New	22,531 $66,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.